Filters: keyword is Drug Evaluation [Clear All Filters]
- 2008
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments,
J Pharmacol Toxicol Methods, vol. 57, no. 2, pp. 114-30.
- 2005
Allometric relationships between the pharmacokinetics of propofol in rats, children and adults,
Br J Clin Pharmacol, vol. 59, no. 6, pp. 705-11.
Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration,
Am J Kidney Dis, vol. 45, no. 2, pp. 360-71.
- 2002
Pharmaco-electroencephalography and pharmacokinetic-pharmacodynamic modeling in drug development: focus on preclinical steps,
Methods Find Exp Clin Pharmacol, vol. 24 Suppl D, pp. 127-8.
- 2000
Pharmacokinetic-pharmacodynamic correlation of lamotrigine, flunarizine, loreclezole, CGP40116 and CGP39551 in the cortical stimulation model,
Epilepsy Res, vol. 40, no. 1, pp. 41-52.
- 1998
Pharmacokinetic-pharmacodynamic modelling of the analgesic effect of alfentanil in the rat using tooth pulp evoked potentials,
J Pharmacol Toxicol Methods, vol. 39, no. 1, pp. 19-27.
- 1996
Applications of pharmacokinetic/pharmacodynamic research in rational drug development,
Methods Find Exp Clin Pharmacol, vol. 18 Suppl C, pp. 53-4.
- 1995
Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine,
J Pharmacol Exp Ther, vol. 275, no. 1, pp. 245-53.
- 1994
Characterization of the pharmacodynamics of several antiepileptic drugs in a direct cortical stimulation model of anticonvulsant effect in the rat,
J Pharmacol Exp Ther, vol. 269, no. 2, pp. 521-8.
- 1993
Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives,
Eur J Drug Metab Pharmacokinet, vol. 18, no. 1, pp. 41-7.
- 1992
Pharmacokinetic considerations on Orgaran (Org 10172) therapy,
Haemostasis, vol. 22, no. 2, pp. 73-84.
